Consistent with its role as a negative regulator of fatty acid synthesis, our previous study showed that BRCA1 inhibited lipogenic actions of insulin-like growth factor I (IGF-I) in breast cancer cells [16]. The gene discussed is IGF1; the disease is breast cancer.